Medicare Advantage Prior Authorization: More Rules, Same Burden

If you're enrolled in a Medicare Advantage plan — or weighing one during the Annual Enrollment Period running October 15 through December 7 — the phrase 'prior authorization' may already feel like a roadblock you've hit before. Your doctor schedules a procedure. The insurance plan says it needs to approve it first. Days pass. Sometimes weeks. Sometimes the answer is no. Federal regulators have heard the complaints, and new rules are coming that will force plans to be more transparent about how they use this tool. But here's the honest truth: prior authorization itself isn't going away, and the burden on patients and their physicians will remain a defining feature of Medicare Advantage for years to come.

Prior authorization is the process by which a Medicare Advantage plan requires your doctor to get advance approval before you receive certain medical services, equipment, or medications. Unlike Original Medicare — which generally pays for any service that is medically necessary and covered under Medicare's national coverage determinations — Medicare Advantage plans are run by private insurers who set their own internal rules about what requires pre-approval. A hip replacement, an MRI, a stay in a skilled nursing facility, inpatient rehabilitation, or even certain prescription drugs may require your physician to submit clinical documentation, wait for a plan reviewer to evaluate it, and receive written approval before your care can proceed. If the plan says no, your care is delayed or denied unless you appeal.

The scale of this problem is substantial. According to CMS.gov data from Medicare Advantage prior authorization and utilization management transparency reports, Medicare Advantage plans collectively processed roughly 35 million prior authorization requests in 2021, denying approximately 2 million of them. That denial rate — around 6% — may sound modest in percentage terms, but it represents 2 million real patients facing real delays or outright refusals. What makes that number more striking is what happens when those denials are challenged: CMS data shows plans overturned approximately 82% of prior authorization denials that beneficiaries formally appealed. If four out of five denials get reversed when someone pushes back, it raises a serious question about whether those initial denials were medically justified in the first place.

The new transparency requirements being phased in by CMS represent a meaningful step forward, even if they fall short of what patient advocates have demanded. Starting with plan year 2026, Medicare Advantage organizations are required to publicly report detailed data on their prior authorization practices — including how many requests they receive, how many they approve, how many they deny, how long approvals take, and how often denials are overturned on appeal. This information will be made available through CMS reporting mechanisms, allowing beneficiaries, researchers, and advocacy groups to compare plans on a dimension that has historically been nearly invisible. When you shop for a Medicare Advantage plan during open enrollment, you will eventually be able to look up not just a plan's premium and star rating, but its actual track record on approving or denying care.

That is a genuine improvement over the status quo. Right now, most beneficiaries choose a Medicare Advantage plan based on monthly premium, drug formulary, and perhaps a star rating. The CMS star rating system — which runs from 1 to 5 stars and is published each fall — does include some measures related to access to care, but it does not give you a clear picture of how aggressively a specific plan uses prior authorization to delay or deny services. A plan might carry a 4-star rating overall while still denying prior authorization requests at a rate significantly higher than its competitors. The new reporting requirements are designed to close that information gap, though it will take time for the data to become widely accessible and easy to interpret during a typical enrollment decision.

What the new rules do not do is limit how often plans can require prior authorization, eliminate the practice for categories of care that are routinely approved anyway, or impose penalties that are truly enforceable in all circumstances. CMS did finalize a rule in 2024 requiring Medicare Advantage plans to respond to urgent prior authorization requests within 72 hours and standard requests within 7 calendar days — a significant improvement over the open-ended timelines that previously existed and sometimes stretched into weeks. But enforcement of those timelines, and the consequences when plans miss them, remains an ongoing concern among patient advocates and healthcare providers. Physicians have reported spending several hours each week on prior authorization paperwork, time that comes directly out of patient care.

Data Snapshot: According to CMS.gov data, there were approximately 7,900 Medicare Advantage plan options available nationwide for 2025, with an average of 43 plans available per county. That means most beneficiaries have real choices — and those choices vary enormously in how aggressively plans use prior authorization. Plans with higher premiums or those operating in more competitive markets may use prior authorization more sparingly as a way to attract and retain members. Lower-premium plans may rely more heavily on utilization management to control costs. When the new transparency data becomes fully accessible, comparing plans on their prior authorization denial rates will be as important as comparing their $0 or low monthly premiums.

For beneficiaries currently enrolled in Medicare Advantage, the most important thing to understand right now is your right to appeal a denial — and to do so quickly. When a Medicare Advantage plan denies a prior authorization request, it must send you a written notice explaining the reason for the denial and your appeal rights. You have the right to request a reconsideration from the plan itself. If the plan upholds its denial, you can escalate to an Independent Review Entity, then to an Administrative Law Judge, and beyond. The first level of appeal — asking the plan to reconsider — must be decided within 72 hours for urgent cases and 30 days for standard cases. Do not assume a denial is final. The 82% overturn rate on appealed denials is your evidence that the system rewards persistence.

It also matters which type of Medicare Advantage plan you are enrolled in. HMO plans — which require you to use a network of providers and typically require referrals from a primary care physician — tend to have more extensive prior authorization requirements than PPO plans, which allow you to see out-of-network providers at higher cost and often have somewhat more flexibility. Special Needs Plans, or SNPs, designed for people with specific chronic conditions or who are dual-eligible for Medicare and Medicaid, may have prior authorization structures tailored to their specific populations. If you have a complex medical condition requiring frequent specialist visits, imaging, or procedures, the plan structure you choose can significantly affect how often you encounter prior authorization barriers.

One alternative worth considering — particularly if prior authorization has been a persistent problem — is returning to Original Medicare paired with a Medigap supplemental policy. Original Medicare does not use prior authorization for most services. If your doctor says you need it and Medicare covers it, you generally receive it without advance insurer approval. A Medigap Plan G policy, for example, covers the Part A hospital deductible ($1,676 in 2025), the Part B coinsurance after the annual deductible ($257 in 2025), and most other cost-sharing gaps, leaving you with relatively predictable out-of-pocket costs. The tradeoff is that Medigap premiums can be substantial — typically ranging from $100 to $250 or more per month depending on your age, location, and the plan letter you choose — and you will need a separate Part D prescription drug plan. But for beneficiaries who have experienced repeated prior authorization denials or delays that affected their health, the freedom of Original Medicare may be worth the additional premium.

The political pressure on Medicare Advantage prior authorization practices has been building for years, driven by congressional investigations, inspector general reports, and high-profile cases of beneficiaries being denied post-acute care that Original Medicare would have covered. A 2022 HHS Office of Inspector General report found that Medicare Advantage plans denied 13% of prior authorization requests for post-acute care — skilled nursing, home health, inpatient rehabilitation — that met Medicare's own coverage criteria, meaning those denials were inappropriate under federal rules. That report accelerated regulatory action and contributed directly to the transparency and timeline rules now being implemented. AARP and other advocacy organizations have continued to push for stronger protections, including legislation that would require Medicare Advantage plans to follow Original Medicare coverage criteria when making prior authorization decisions — a change that has not yet been enacted.

Before enrolling in any Medicare Advantage plan, call the plan directly and ask which services require prior authorization. Ask your doctor's office which plans they find easiest to work with — physicians and their staff deal with prior authorization every day and often have strong opinions about which plans are reasonable and which create unnecessary barriers. During the Annual Enrollment Period each fall, use Medicare's Plan Finder tool at Medicare.gov to compare plans on premium, formulary, and star rating. Watch for CMS to make prior authorization transparency data more accessible in coming enrollment cycles — that data will eventually be as searchable as a plan's monthly premium. If you are already in a plan and facing a denial, file your appeal in writing, ask your doctor to submit a letter of medical necessity, and escalate through every level of the appeals process before accepting a no. The rules are changing slowly, but your rights as a beneficiary are real, legally protected, and worth exercising.